Cell Panel Screening
Discovery extended with high quality, actionable data
High-throughput cell panel screening is a key drug development tool for identifying sensitive or resistant tumor types and genomic features governing response.
Offering experience in high-throughput phenotypic screening and drug profiling across large panels of cancer cell lines to provide efficacy and toxicity data for lead oncology therapeutics.
Study drug response by identifying sensitive and resistant cells, aid patient stratification for drug candidates and combinations, and receive bioinformatics analysis that links molecular features with phenotypic response.
2D and 3D OncoSignature cell panel screening
Providing phenotypic cell panel screening with advanced 2D and 3D platforms to test efficacy and antiproliferative effects to streamline therapeutic pipelines and enhance patient stratification strategies.
Leverage a broad panel of 300 (2D) and 200 (3D) characterized cancer cell lines and analyze large screening datasets with proprietary Chalice™ software with first results in one month.
Providing phenotypic cell panel screening with advanced 2D and 3D platforms to test efficacy and antiproliferative effects to streamline therapeutic pipelines and enhance patient stratification strategies.
Leverage a broad panel of 300 (2D) and 200 (3D) characterized cancer cell lines and analyze large screening datasets with proprietary Chalice™ software with first results in one month.
Long-term cell panel screening
2D OncoSignature™ long-term assay drug discovery service that profiles slow acting or epigenetic drugs in 384-well plates for 10 days across a diverse, clinically relevant panel of 248 cell lines.
2D OncoSignature™ long-term assay drug discovery service that profiles slow acting or epigenetic drugs in 384-well plates for 10 days across a diverse, clinically relevant panel of 248 cell lines.
Combination screening services
Screen large numbers of therapeutic agents to discover novel combination pairings that boost the therapeutic profile of a lead drug and enhance treatment outcomes.
Screen large numbers of therapeutic agents to discover novel combination pairings that boost the therapeutic profile of a lead drug and enhance treatment outcomes.
Featured resources
Questions?
We’re here to help.
Contact us Please note that product labeling (such as kit insert, product label, and kit box) may be different compared to the company branding. Please contact your local representative for further details.